Answers are grounded in this paper and cite their sources.
Establishes a DNA detection method for chickpea residue in food, suggesting improved safety measures.
Chickpeas, a high-protein emerging plant-based food source, face allergenicity concerns necessitating robust residue detection in the food supply chain. This study established a DNA detection method by real-time PCR targeting the Chloroplast import apparatus 2-like gene fragment (chromosome Ca7) for detection of chickpea residue, optimized for ISO standardization. Utilizing molecular biomarker analysis, the method demonstrated an absolute limit of detection (LOD) of 5 copies and a LOD95% of 4.08 copies, enabling detection at 0.01% (w/w) mass fraction. Robustness yielded an RSD of 0.86%. Specificity was confirmed against 49 non-target species, and inclusivity was validated across 9 chickpea varieties. International collaborative trials exhibited 0% false positive/negative rates, a LOD95% of 3.601 copies, a probability of detection (POD) of 0.638, and an inter-laboratory standard deviation of 0.331. Successful application to real food samples confirmed applicability. This validated method, advanced to the ISO/CD TS 24910-1 stage, provides critical technical support for global food safety by detecting chickpea residues.
No takes yet. Share an insight, caveat, or question.
Man et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: